Pharma M&A Deals 2023 - Top Themes - Thematic Research

Pharma M&A Deals 2023 - Top Themes - Thematic Research

Summary

This report analyzes the disruptive themes that have driven M&A activity in 2023 in the Pharma Sector

The global pharma sector in 2023 witnessed deals worth $233 billion, a growth of 81% compared to 2022. In terms of deal volume also, there was a growth of 14% to record 937 M&A deals in 2023. Pharma sector recorded 46 mega deals (defined as any deal valued at more than $1 billion) in 2023, an increase of 92% compared to the previous year.

Scope

This report provides an overview of merger and acquisition activity globally in 2023 in Pharma Sector

It identifies the themes driving most notable to deals announced in 2023 in the Pharma Sector

Reasons to Buy

Companies who invest in the right themes become success stories; those who miss the big themes end up as failures. If you want to understand the themes that drive an industry, simply look at the list of recent mergers and acquisitions (M&A).

In this report we have listed down the most notable deals in pharma sector to make it easy for our clients to get a view of themes disrupting the sector and prepare for the future.